Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Gemcitabine and Docetaxel in Advanced Carcinoma of the Urothelium

NCT00004223 is registered in ClinicalTrials.gov with Eastern Cooperative Oncology Group as lead sponsor.

NCT NCT00004223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Gemcitabine and Docetaxel in Advanced Carcinoma of the Urothelium
Lead sponsor
Eastern Cooperative Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
February 24, 2000
Completion date
Not reported
Enrollment
Not reported
Sites
76

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, transitional cell cancer of the renal pelvis and ureter, urethral cancer